News

Germany-based wexxeljahre Wants to Help Women Find Providers to Support Them Throughout Menopause

Newly launched German startup wexxeljahre wants to make it easier for women to find a provider to support them in their journey through menopause. On their website the company now lists providers recommended by its users, offers webinars and educational content around the menopause. wexxeljahre Founder Anke Sinningen explains: “It is unfortunately still the case that many doctors know far too little…

Natural Cycles Partners with ŌURA on Body Temperature-based Fertility Tracking & Birth Control

ŌURA, the company behind the smart ring that delivers personalized health data, insights, and daily guidance, and Natural Cycles, the FDA-cleared birth control app have are teaming up: Starting today Natural Cycles users will now be able to sync temperature trend data straight from the Oura Ring, allowing them to track their temperature trends automatically while they sleep rather than manually taking…

Mira Launches Ovum Wand to Predict Menopause and Monitor Fertility Status for Women over 35

Mira’s new Ovum Wand provides lab-accurate detection of the follicle-stimulating hormone (FSH) to predict menopause, evaluate fertility and assist in ovulation prediction. The FDA has listed Mira’s new Mira Ovum Wand as an over-the-counter tool to detect the follicle-stimulating hormone (FSH) in urine. Starting October 2022, the product will be available to US customers. The wands help monitor FSH levels to predict…

Kindbody Acquires Gestational Surrogacy Agency ARR to Further Expand Its Continuum of Care

Kindbody, a leading fertility clinic network and family-building benefits provider for employers offering comprehensive virtual and in-person care, announced today the acquisition of Chicago-based Alternative Reproductive Resources (ARR), a leading gestational surrogacy agency. The acquisition will bring gestational surrogacy in-house, delivering a seamless continuum of patient care. The ARR team will join Kindbody as part of its expanded KindEOS division, the company’s in-house…

Femtech Trends: Gen Z Health, Femtech Investment Round-up & Startup Spotlight

Every Monday we share a quick “best of” from the week that was with our Inner Circle members. What’s trending in the Femtech Insider community and beyond? We’ve got you covered! In this week’s brief we talk about… Report: GenZ Healthcare Femtech Investment Round-up: July 2022 Startup Spotlight: Qvin & Oxyto And more! Spotlight: GenZ Health Caraway, a femtech company with plans to take on the societal and…

Femtech Investment Round-up: July 2022

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is July 2022’s round-up. Investments Male contraception company YourChoice Therapeutics adds $15M in Series A funding to kick off human trials. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on:…

Organon Teams Up with Cirqle Biomedical to Advance Non-Hormonal, On-Demand Contraception

Cirqle Biomedical is a pre-clinical stage life science company with the goal of developing a first-in-class non-hormonal contraceptive that can help address the demand from millions of women for an effective contraceptive with minimal side-effects. Cirqle Biomedical’s approach to contraception is based on engineering mucus to leverage the natural barrier properties of cervical mucus. Cirqle Biomedical was launched in 2019 in Copenhagen,…

Mymee Acquires Breakthrough Health, the Company Behind Leading Multiple Sclerosis App Emilyn

Autoimmune disease happens when the body’s natural defense system can’t tell the difference between own cells and foreign cells, causing the body to mistakenly attack normal cells. One of the most common autoimmune diseases is multiple sclerosis (in short MS), a potentially disabling disease of the central nervous system. In MS, the immune system attacks the protective sheath that covers nerve fibers and causes…